Cash flow Arecor Therapeutics plc

Equities

AREC

GB00BMWLM973

Biotechnology & Medical Research

Market Closed - London S.E. Other stock markets 16:35:18 06/09/2024 BST			5-day change	1st Jan Change
81.50 ^GBX	+3.82%		-5.78%	-55.34%

07-23	Arecor Therapeutics Completes Retail Offer	MT
07-22	Arecor Therapeutics Raises GBP7 Million via Share Placing, Subscription, retail offer	MT

6512b924df4dc.DFhdTvo2EJsrQHR6l0h6Pz3XtnI9L8JaFkIrZ8_m6Qo.fA45FIN-SatSAxAX_DEgRW6u6SJ4G5BsIjpqOITLkFo_bysbvANAqWorOQ

Published financial data: ARECOR THERAPEUTICS PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	1.89M	1.7M	1.16M	2.4M	4.57M
Total Revenues	1.89M	1.7M	1.16M	2.4M	4.57M
Gross Profit	1.89M	1.7M	1.16M	2.4M	4.57M
Selling General & Admin Expenses, Total	1.61M	1.64M	2.39M	5.38M	8.91M
R&D Expenses	3.56M	3.94M	5.39M	8.61M	5.98M
Other Operating Expenses	-592K	-452K	-640K	-1.13M	-1.14M
Other Operating Expenses, Total	4.58M	5.13M	7.14M	12.86M	13.75M
Operating Income	-2.69M	-3.43M	-5.98M	-10.46M	-9.18M
Interest Expense, Total	-13.07K	-82K	-22K	-26K	-15K
Interest And Investment Income	9.41K	2.98K	1K	109K	284K
Net Interest Expenses	-3.66K	-79.02K	-21K	83K	269K
Other Non Operating Income (Expenses)	-	-5.29K	-	5K	5K
EBT, Excl. Unusual Items	-2.69M	-3.51M	-6M	-10.37M	-8.9M
Other Unusual Items	-	-	-947K	-171K	-
EBT, Incl. Unusual Items	-2.69M	-3.51M	-6.94M	-10.54M	-8.9M
Income Tax Expense	-502K	-760K	-776K	-1.28M	-347K
Earnings From Continuing Operations	-2.19M	-2.75M	-6.17M	-9.26M	-8.55M
Net Income to Company	-2.19M	-2.75M	-6.17M	-9.26M	-8.55M
Net Income - (IS)	-2.19M	-2.75M	-6.17M	-9.26M	-8.55M
Net Income to Common Incl Extra Items	-2.19M	-2.75M	-6.17M	-9.26M	-8.55M
Net Income to Common Excl. Extra Items	-2.19M	-2.75M	-6.17M	-9.26M	-8.55M
Per Share Items
Net EPS - Basic	-0.14	-0.17	-0.27	-0.32	-0.28
Basic EPS - Continuing Operations	-0.14	-0.17	-0.27	-0.32	-0.28
Basic Weighted Average Shares Outstanding	15.77M	16.25M	23.03M	28.94M	30.62M
Net EPS - Diluted	-0.14	-0.17	-0.27	-0.32	-0.28
Diluted EPS - Continuing Operations	-0.14	-0.17	-0.27	-0.32	-0.28
Diluted Weighted Average Shares Outstanding	15.77M	16.25M	23.03M	28.94M	30.62M
Normalized Basic EPS	-0.11	-0.14	-0.16	-0.22	-0.18
Normalized Diluted EPS	-0.11	-0.14	-0.16	-0.22	-0.18
Supplemental Items
EBITDA	-2.61M	-3.34M	-5.9M	-10.26M	-8.88M
EBITA	-2.68M	-3.42M	-5.97M	-10.37M	-9.08M
EBIT	-2.69M	-3.43M	-5.98M	-10.46M	-9.18M
EBITDAR	-	-	-	-	-8.44M
Effective Tax Rate - (Ratio)	18.66	21.64	11.17	12.16	3.9
Total Current Taxes	-502K	-760K	-776K	-	-
Normalized Net Income	-1.68M	-2.2M	-3.75M	-6.48M	-5.56M
Interest on Long-Term Debt	7.62K	17.98K	22K	18K	15K
Supplemental Operating Expense Items
General and Administrative Expenses	1.61M	1.64M	2.39M	-	-
Research And Development Expense From Footnotes	3.56M	3.94M	5.39M	8.61M	5.98M
Net Rental Expense, Total	-	-	-	-	436K
Imputed Operating Lease Interest Expense	-	-	-	-	167K
Imputed Operating Lease Depreciation	-	-	-	-	269K
Stock-Based Comp., R&D Exp. (Total)	-	-	-	-	156K
Stock-Based Comp., Other (Total)	460K	318K	484K	503K	483K
Total Stock-Based Compensation	460K	318K	484K	503K	639K

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	3.07M	2.9M	18.32M	4.76M	5.09M
Short Term Investments	-	-	-	8.04M	1.66M
Total Cash And Short Term Investments	3.07M	2.9M	18.32M	12.81M	6.75M
Accounts Receivable, Total	497K	78.3K	712K	2.22M	2.27M
Other Receivables	314K	782K	859K	1.32M	1.06M
Total Receivables	811K	860K	1.57M	3.54M	3.32M
Inventory	-	-	-	1.13M	771K
Prepaid Expenses	30.94K	63.76K	628K	-	323K
Total Current Assets	3.92M	3.82M	20.52M	17.48M	11.17M
Gross Property Plant And Equipment	1.18M	1.4M	1.51M	2.2M	2.38M
Accumulated Depreciation	-888K	-1.03M	-1.18M	-1.36M	-1.55M
Net Property Plant And Equipment	295K	375K	328K	838K	834K
Goodwill	-	-	-	1.48M	1.48M
Other Intangibles, Total	46.53K	38.2K	30K	1.92M	1.81M
Other Long-Term Assets, Total	48K	48K	48K	48K	77K
Total Assets	4.31M	4.28M	20.92M	21.76M	15.38M
Liabilities
Accounts Payable, Total	366K	464K	518K	1.71M	2.25M
Accrued Expenses, Total	271K	691K	1.17M	1.27M	2.13M
Current Portion of Leases	97.73K	105K	126K	202K	118K
Current Income Taxes Payable	46.61K	51.11K	85K	120K	100K
Unearned Revenue Current, Total	241K	80K	349K	206K	232K
Other Current Liabilities	15.75K	16.31K	23K	217K	321K
Total Current Liabilities	1.04M	1.41M	2.27M	3.73M	5.15M
Long-Term Debt	-	1.7M	-	-	-
Long-Term Leases	60.39K	192K	105K	86K	220K
Deferred Tax Liability Non Current	-	-	-	496K	452K
Other Non Current Liabilities	-	212K	-	-	28K
Total Liabilities	1.1M	3.51M	2.37M	4.31M	5.85M
Common Stock, Total	26.73K	27.16K	278K	306K	306K
Additional Paid In Capital	11.59M	11.59M	23.35M	28.98M	28.98M
Retained Earnings	-9.14M	-11.89M	-17.05M	-26.18M	-34.72M
Comprehensive Income and Other	727K	1.04M	11.97M	14.35M	14.97M
Total Common Equity	3.21M	774K	18.55M	17.46M	9.53M
Total Equity	3.21M	774K	18.55M	17.46M	9.53M
Total Liabilities And Equity	4.31M	4.28M	20.92M	21.76M	15.38M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	15.77M	27.68M	27.84M	30.62M	30.63M
ECS Total Common Shares Outstanding	15.77M	16.29M	27.84M	30.62M	30.63M
Book Value / Share	0.2	0.05	0.67	0.57	0.31
Tangible Book Value	3.16M	736K	18.52M	14.05M	6.23M
Tangible Book Value Per Share	0.2	0.05	0.67	0.46	0.2
Total Debt	158K	2M	231K	288K	338K
Net Debt	-2.92M	-903K	-18.08M	-12.52M	-6.41M
Debt Equivalent Oper. Leases	-	-	-	-	3.49M
Account Code - Inventory Valuation	-	3	3	3	3
Inventories - Raw Materials, Total	-	-	-	719K	292K
Inventories - Finished Goods, Total	-	-	-	412K	479K
Machinery, Total	673K	706K	762K	1.17M	1.18M
Full Time Employees	-	29	37	51	50
Part Time Employees	-	1	-	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-2.19M	-2.75M	-6.17M	-9.26M	-8.55M
Depreciation & Amortization - CF	143K	160K	163K	248K	390K
Amortization of Goodwill and Intangible Assets - (CF)	8.33K	8.33K	8K	91K	97K
Depreciation & Amortization, Total	152K	169K	171K	339K	487K
Amortization of Deferred Charges, Total - (CF)	-	-	-	2K	9K
Stock-Based Compensation (CF)	460K	318K	484K	503K	638K
Other Operating Activities, Total	801K	-338K	483K	-705K	688K
Change In Accounts Receivable	446K	384K	-1.26M	-48K	-1M
Change In Inventories	11.39K	-	-	587K	360K
Change In Accounts Payable	-127K	364K	838K	-2.2M	1.38M
Change in Other Net Operating Assets	-	-	-	-	157K
Cash from Operations	-459K	-1.86M	-5.45M	-10.78M	-5.84M
Capital Expenditure	-32.3K	-52.29K	-69K	-299K	-151K
Sale of Property, Plant, and Equipment	-	-	-	-	5K
Cash Acquisitions	-	-	-	284K	-
Sale (Purchase) of Intangible assets	-	-	-	-46K	-
Investment in Marketable and Equity Securities, Total	-	-	-	-8.04M	6.38M
Other Investing Activities, Total	9.41K	2.98K	1K	109K	284K
Cash from Investing	-22.89K	-49.32K	-68K	-7.99M	6.52M
Long-Term Debt Issued, Total	-	1.91M	2.5M	-	38K
Total Debt Issued	-	1.91M	2.5M	-	38K
Short Term Debt Repaid, Total	-	-	-	-295K	-
Long-Term Debt Repaid, Total	-69.89K	-49.22K	-112K	-165K	-203K
Total Debt Repaid	-120K	-49.22K	-112K	-460K	-203K
Issuance of Common Stock	1.87K	423	20M	6M	-
Other Financing Activities, Total	-13.07K	-82.99K	-1.46M	-380K	-15K
Cash from Financing	-131K	1.77M	20.93M	5.16M	-180K
Foreign Exchange Rate Adjustments	-27.06K	-42.94K	5K	62K	-171K
Net Change in Cash	-640K	-175K	15.42M	-13.55M	328K
Supplemental Items
Cash Interest Paid	13.07K	17.98K	22K	28K	15K
Cash Income Tax Paid (Refund)	-1.27M	-295K	-758K	-734K	-1.28M
Levered Free Cash Flow	-1.96M	-1.48M	-3.6M	-7.14M	-3M
Unlevered Free Cash Flow	-1.95M	-1.43M	-3.59M	-7.12M	-2.99M
Change In Net Working Capital	459K	-282K	437K	1.09M	-1.76M
Net Debt Issued / Repaid	-120K	1.86M	2.39M	-460K	-165K

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-47.47	-49.89	-29.64	-30.63	-30.88
Return on Total Capital	-61.88	-69.84	-34.67	-35.8	-41.54
Return On Equity %	-99.68	-138.25	-63.85	-51.44	-63.41
Return on Common Equity	-99.68	-138.25	-63.85	-51.44	-63.41
Margin Analysis
Gross Profit Margin %	100	100	100	100	100
SG&A Margin	84.94	96.7	206.3	223.93	194.9
EBITDA Margin %	-138.07	-196.75	-509.59	-426.97	-194.18
EBITA Margin %	-141.72	-201.44	-515.46	-431.46	-198.51
EBIT Margin %	-142.16	-201.93	-516.15	-435.25	-200.63
Income From Continuing Operations Margin %	-115.79	-162.13	-532.73	-385.35	-187.05
Net Income Margin %	-115.79	-162.13	-532.73	-385.35	-187.05
Net Avail. For Common Margin %	-115.79	-162.13	-532.73	-385.35	-187.05
Normalized Net Income Margin	-88.97	-129.31	-323.73	-269.74	-121.65
Levered Free Cash Flow Margin	-262.59	-87.04	-310.91	-297.18	-65.62
Unlevered Free Cash Flow Margin	-260.59	-84.02	-309.73	-296.5	-65.41
Asset Turnover
Asset Turnover	0.2	0.4	0.09	0.11	0.25
Fixed Assets Turnover	1.89	5.06	3.29	4.12	5.47
Receivables Turnover (Average Receivables)	1.42	5.9	2.93	1.64	3.12
Short Term Liquidity
Current Ratio	3.78	2.71	9.05	4.69	2.17
Quick Ratio	3.75	2.67	8.77	4.38	1.96
Operating Cash Flow to Current Liabilities	-0.44	-1.32	-2.4	-2.89	-1.13
Days Sales Outstanding (Average Receivables)	257.17	62.05	124.5	222.3	117.01
Long Term Solvency
Total Debt/Equity	4.93	257.87	1.25	1.65	3.55
Total Debt / Total Capital	4.7	72.06	1.23	1.62	3.43
LT Debt/Equity	1.88	244.27	0.57	0.49	2.31
Long-Term Debt / Total Capital	1.79	68.26	0.56	0.48	2.23
Total Liabilities / Total Assets	25.49	81.94	11.34	19.8	38.04
EBIT / Interest Expense	-205.66	-41.81	-271.68	-402.27	-611.67
EBITDA / Interest Expense	-194.07	-39.75	-263.91	-389.23	-579.2
(EBITDA - Capex) / Interest Expense	-196.54	-40.39	-267.05	-400.73	-589.27
Total Debt / EBITDA	-0.06	-0.61	-0.04	-0.03	-0.04
Net Debt / EBITDA	1.15	0.28	3.11	1.24	0.74
Total Debt / (EBITDA - Capex)	-0.06	-0.6	-0.04	-0.03	-0.04
Net Debt / (EBITDA - Capex)	1.13	0.27	3.08	1.2	0.73
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-44.62	-10.23	-31.8	107.51	90.3
Gross Profit, 1 Yr. Growth %	-44.62	-10.23	-31.8	107.51	90.3
EBITDA, 1 Yr. Growth %	111.65	27.93	76.68	73.87	-12.44
EBITA, 1 Yr. Growth %	104.89	27.61	74.53	73.7	-11.43
EBIT, 1 Yr. Growth %	104.26	27.52	74.36	74.99	-11.28
Earnings From Cont. Operations, 1 Yr. Growth %	117.58	25.71	124.16	50.11	-7.62
Net Income, 1 Yr. Growth %	117.58	25.71	124.16	50.11	-7.62
Normalized Net Income, 1 Yr. Growth %	101.26	30.48	70.79	72.91	-13.19
Diluted EPS Before Extra, 1 Yr. Growth %	57.58	22	58.12	19.49	-12.71
Accounts Receivable, 1 Yr. Growth %	62.11	-84.25	812.82	211.1	241.57
Inventory, 1 Yr. Growth %	-	-	-	-	-31.83
Net Property, Plant and Equip., 1 Yr. Growth %	-19.49	27.18	-12.77	155.49	-0.48
Total Assets, 1 Yr. Growth %	163.75	-0.51	388.35	4.03	-29.35
Tangible Book Value, 1 Yr. Growth %	582.02	-76.73	2.42K	-24.12	-55.66
Common Equity, 1 Yr. Growth %	528.92	-75.88	2.3K	-5.9	-45.42
Cash From Operations, 1 Yr. Growth %	408.51	304.67	193.48	97.8	-45.82
Capital Expenditures, 1 Yr. Growth %	466.13	61.91	32.69	333.33	-49.5
Levered Free Cash Flow, 1 Yr. Growth %	-	-	143.59	98.34	-57.52
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	151.37	98.65	-57.58
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-21.75	18.96	98.72
Gross Profit, 2 Yr. CAGR %	-	-	-21.75	18.96	98.72
EBITDA, 2 Yr. CAGR %	-	-	50.34	75.27	22.67
EBITA, 2 Yr. CAGR %	-	-	49.24	74.11	23.32
EBIT, 2 Yr. CAGR %	-	-	49.11	74.67	23.9
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	67.85	83.43	17.75
Net Income, 2 Yr. CAGR %	-	-	67.85	83.43	17.75
Normalized Net Income, 2 Yr. CAGR %	-	-	49.27	71.84	21.82
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	38.88	37.45	2.13
Accounts Receivable, 2 Yr. CAGR %	-	-	19.66	432.89	78.48
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	5.42	49.29	59.46
Total Assets, 2 Yr. CAGR %	-	-	120.43	125.4	-14.27
Tangible Book Value, 2 Yr. CAGR %	-	-	142.03	336.96	-41.99
Common Equity, 2 Yr. CAGR %	-	-	140.46	374.89	-28.33
Cash From Operations, 2 Yr. CAGR %	-	-	244.66	140.94	3.52
Capital Expenditures, 2 Yr. CAGR %	-	-	46.16	139.79	47.93
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	119.81	-8.71
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	123.46	-8.67
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	8.31	39.13
Gross Profit, 3 Yr. CAGR %	-	-	-	8.31	39.13
EBITDA, 3 Yr. CAGR %	-	-	-	57.8	38.53
EBITA, 3 Yr. CAGR %	-	-	-	56.99	38.46
EBIT, 3 Yr. CAGR %	-	-	-	57.28	38.84
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	61.72	45.94
Net Income, 3 Yr. CAGR %	-	-	-	61.72	45.94
Normalized Net Income, 3 Yr. CAGR %	-	-	-	56.77	36.34
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-